Metsera stock plunges after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 ...

Technology stocks were among the biggest gainers in a premarket rally Monday, fueled by hopes the government shutdown might ...

The vote was 60-40 on a measure to take up House-passed spending legislation that required 60 votes under the Senate's filibuster procedures. Eight members of the Democratic caucus joined almost all ...

Novo Nordisk shares rose Monday after the Danish drugmaker withdrew from a bidding war with Pfizer for U.S. obesity drug maker Metsera. Shares climbed as much as 3.5% in early European trade. Pfizer ...

Shares of Novo Nordisk increased after the company withdrew its bid for U.S. weight loss drug maker Metsera, allowing Pfizer to secure a $10 billion deal. This move grants Pfizer entry into the ...

Shares climbed as much as 3.5% in early European trade after Pfizer agreed to buy Metsera in a deal that could be worth more ...

Novo Nordisk saw a slight rise in shares after withdrawing its bid for U.S. weight loss drug company Metsera, losing out to Pfizer in a bidding war. Pfizer secured a $10 billion deal, marking a ...

COPENHAGEN (Reuters) -Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its ...

Welcome back! For the first time in a while, the U.S. stock market is falling. The S&P 500 Index has shed 4% from its peak on October 29, while the tech-heavy Nasdaq Composite Index is down 6%. Is ...

A speeding car fleeing police slammed into a crowded bar early Saturday, killing four people and injuring 11 in Tampa, Fla.

After a bidding war erupted between Pfizer and Novo Nordisk over the fledgling obesity drugmaker, Metsera sided with its original suitor in a final agreement announced late Friday evening.

A power struggle over Nexperia, a Chinese-owned Dutch semiconductor maker, is impacting global auto production. The Dutch ...